The technologies in stent have undergone significant change in recent years, with bare metal coronary stents to bioabsorbable stents. The rising wave of new technologies, such as drug-eluting stents (DES) and bioabsorbable stents are creating significant potential for advanced stent implants in various coronary platforms due to increasing adoption of minimally invasive techniques.
To download report brochure, please go to https://www.lucintel.com/technology-stent-market.aspx and click "report brochure" tab from the menu.
In stent market, various technologies, such as drug-eluting stents (DES), bare-metal coronary stents, and bioabsorbable stents, iliac stents, femoral-popliteal stents, renal and related stents, and carotid stents are used in the coronary and peripheral vascular applications. Increasing adoption of minimally invasive techniques, rising number of cardiovascular surgeries, and hectic lifestyle coupled with rising geriatric population base are creating opportunities for various stent technologies.
Lucintel, a leading global management consulting and market research firm with over 1,000 clients worldwide, has analyzed the technologies used in stent market and it has now published a comprehensive research report titled “Technology Landscape, Trends and Opportunities in the Stent Market”. This report analyzes technology maturity, degree of disruption, competitive intensity, market potential and other parameters of various technologies in stent market.
Lucintel study finds that stent market is forecast to grow at a CAGR of 7% from 2019 to 2024. Coronary stent is the largest segment of this market and is growing at above average growth. Terumo Corporation, Stentys, Microport Scientific Corporation, Medtronic, Elixir Medical Corporation, C. R. Bard, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen, and Abbott Laboratories are among the major players in the stent market.
The Lucintel report serves as a catalyst for growth as it provides a comprehensive data and analysis on trends, key drivers, and directions. The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications the stent technology by technology, application, and region as follows:
Technology Readiness by Technology Type
Competitive Intensity and Regulatory Compliance
Disruption Potential by Technology Type
Trends and Forecasts by Technology Type [$M shipment analysis from 2013 to 2024]:
• Drug-Eluting Stents (DES)
• Bare-Metal Coronary Stents
• Bioabsorbable Stents
• Iliac Stents
• Femoral-Popliteal Stents
• Renal and Related Stents
• Carotid Stents
Technology Trends and Forecasts by Application [$M shipment analysis from 2013 to 2024]:
• Coronary
o Drug-Eluting Stents (DES)
o Bare-Metal Coronary Stents
o Bioabsorbable Stents
• Peripheral Vascular
o Iliac Stents
o Femoral-Popliteal Stents
o Renal and Related Stents
o Carotid Stents
Technology Trends and Forecasts by Region [$M shipment analysis for 2013 – 2024]:
• North America
– United States
– Canada
– Mexico
• Europe
– United Kingdom
– Germany
– France
• Asia Pacific
– Japan
– China
– South Korea
– India
• The Rest of the World
Latest Developments and Innovations in the Stent Technologies
Companies / Ecosystems
Strategic Opportunities by Technology Type

A more than 150-pages of research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link…… or [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.